BeHealth Solutions LLC, based in Charlottesville, VA, has licensed its rights in SHUTi to Pear Therapeutics, discontinuing its offering and support for the program.
For individuals seeking information about the new FDA-authorized prescription digital therapeutic developed by Pear from SHUTi, they can visit www.somryst.com. Additionally, those interested in SHUTi research studies can find more details at https med.virginia.edu bht participate Archives.
Generated from the website